Camilo Acero

Camilo Acero joined Ontario Genomics in 2014. In his current role, he is responsible for implementing the organization’s digital strategy and supporting all internal and external communications content and design. Since joining Ontario Genomics, Camilo has implemented the development, launch, refresh and maintenance of the organization’s website, microsites and newsletters to support program execution, and information access, education, and engagement for all stakeholders.

Camilo has a bachelor’s degree in advertising and has worked in communications and marketing for fifteen years in both the corporate and not-for-profit sectors in the US and Canada. Camilo brings his experience to Ontario Genomics to successfully implement communications strategies, marketing campaigns, branding, media planning, web maintenance, content management, social media strategies and event organization.

Sinèad Anderson

Sinèad Anderson joined Ontario Genomics in April 2023. In this role, she is responsible for advancing the strategic initiatives of leadership through senior level coordination, communication, and stakeholder relationship support. Operationally she oversees office and administrative coordination and is also a key facilitator of organizational governance as Secretary to the Board of Directors.

Sinèad brings extensive experience from both the public and private sectors. Previously, she served 10 years in various Ontario government and legislative roles before diving into the burgeoning cannabis industry where she supported Aurora Cannabis Inc. through recreational legalization and beyond.

Sinèad earned her Honours Bachelor of Arts from the University of Ottawa with Double Majors in Psychology and Criminology and also holds a Certificate of Fundamentals of Biomedical Sciences I from the University of Toronto.

Maggie Blood

Maggie Blood joined the team in 2023 to help spread the word about all the fascinating projects Ontario Genomics has, is and will be working on, including the BioCreate Program.

After spending over a decade in radio news broadcasting in eastern Ontario and Toronto, Maggie applied those writing, research, relationship building and communications skills during a brief stint working behind the scenes in municipal politics before running the media relations operations at the Ontario Dental Association for nearly seven years.

Maggie earned her radio broadcast diploma from Humber College and has been taking Indigenous studies courses at the University of Alberta and University of Toronto in her spare time.

Elaine Corbett

Dr. Elaine Corbett joined Ontario Genomics in July 2014. Currently, she is responsible for leading and managing the Strategic Partnership team. Elaine is responsible for developing and leveraging strategic partnerships and common interests with provincial, national and international public and private sector organizations (industries, foundations, government departments, angel investors, VCs etc.) to enable Ontario Genomics’ strategic plan and support synergistic advancement of genomics and engineering biology solutions across Ontario’s priority bio-economic sectors. She has spearheaded strategic reports and partnership opportunities to advance the genomics and engineering biology ecosystem in Ontario and Canada, including driving key initiatives to support the cellular agriculture and biomanufacturing ecosystems more broadly.

Elaine brings over 15 years of progressive leadership experience, working in industry, not-for-profit and academic sectors. Before joining Ontario Genomics, Elaine was a Project Manager at SQI Diagnostics, a Toronto-based biotech company, where she managed multidisciplinary programs for advanced microarray diagnostics. Previously, she was a Senior Field Application Scientist at Axela, a biotech company which develops diagnostic platforms and applications, where her focus was on client management, technical sales and product development.

Elaine received her Honors BSc in Biomedical Science from University College Cork, Ireland. She received her Ph.D. in Biochemistry from the Faculty of Medicine and Dentistry at the University of Alberta, where her work focused on the endoplasmic reticulum and the chaperones involved in protein folding and completed a postdoctoral fellowship in the Cell Biology Program at the Hospital for Sick Children, Toronto, Ontario, where her work focused on cell-mediated immunity and phagocytosis.

Joyce Dao

Joyce joined Ontario Genomics in October 2023 as a Senior Accountant with the main focus on supporting OG Programs as the Finance Business Partner. Joyce has passion and deep technical expertise in streamlining financial processes, data modeling, system implementations, and optimization.

Joyce brings over 15 years of progressive accounting and financial management experience, including 10 years in senior finance roles across a number of not-for-profit organizations in Ontario.

Michael Dorrington

Dr. Michael Dorrington joined Ontario Genomics in 2020. In his current role, he supports the implementation of strategic initiatives to bring new genomic-derived solutions to Ontario’s key sectors. Mike helps build effective relationships by connecting, enabling and working with leading academics and diverse partners and partner organizations to advance collaborative investment opportunities. He is the main point of contact for several funded projects.

Before joining Ontario Genomics, Mike was a post-doctoral fellow in the Laboratory of Immune System Biology at the National Institute of Allergy & Infectious Diseases outside of Washington, DC. In this position, he studied the many roles of antiviral cytokines in inflammation and antibacterial immune responses using cutting-edge genomic and transcriptomic technologies. He was also a post-doctoral representative to the NIH’s Immunology Interest Group.

Mike has a Ph.D. in Infection & Immunity from McMaster University and a B.Sc. in Life Sciences from the University of British Columbia. During his Ph. D., he held the Canadian Thoracic Society/Canadian Lung Association Doctoral Studentship for which he helped develop novel mouse models of bacterial infection.

Liz Edmonds

Liz Edmonds joined Ontario Genomics in June 2022. In her current role, she supports the implementation of strategic initiatives aimed at bringing new genomic-derived solutions to Ontario’s key sectors. Liz helps build effective relationships by connecting, enabling and working with leading academics and diverse partners and partner organizations to advance collaborative investment opportunities, and she is the main point of contact for several funded projects.

Prior to joining Ontario Genomics, Liz was the Research Manager for the Drinking Water Research Group at the University of Toronto for over a decade, where she managed multidisciplinary research projects and developed genomic and proteomic assays to assess water treatment performance. Previously, she was a Molecular Biologist for a plant trait improvement biotech company and a Research Scientist for a drug design company.

Liz received her MSc in Structural Biology (NMR) from York University and a BScH in Biochemistry from Queen’s University.

Koula Ferreira

Koula Ferreira joined Ontario Genomics in October 2015. She supports the Executive Office and the day-to-day running of the Ontario Genomics office as well as assists the Finance Deparment with the accounting processes. Koula’s prior work in the retail industry and recruitment/payroll services expanded her abilities in accounts payable, accounts receivable and collections. Koula has a HR certificate from George Brown College and has studied business administration.

Elizabeth Gray

Dr. Elizabeth Gray joined Ontario Genomics in 2023. In her current role, she provides leadership to a funding initiative aimed at supporting SMEs in health, cleantech and agri-food sectors seeking to commercialize genomics and engineering biology research and technologies, ultimately bringing innovative solutions to the Canadian and International markets.

Elizabeth brings 10 years of progressive leadership experience to this role, having worked in both the public and private sectors. Prior to joining Ontario Genomics, Elizabeth was a VP at a healthcare investment firm, DRI Capital. She also held progressive positions at Eli Lilly Canada, working in both the commercial and medical divisions. Notably, Elizabeth was the Medical Director, Neuroscience, where she built the medical team and launched products in the neuroscience portfolio, from regulatory submissions, to launch readiness and post launch activities. Elizabeth also worked at CCRM (Center for Commercialization of Regenerative Medicine) and CAMH (Center for Addiction and Mental Health), where she evaluated early-stage technologies for their commercialization potential and participated in fund raising activities.

She received her PhD from the University of Toronto, Department of Molecular Genetics and focused on neuronal cell signaling. Her MSc is from McGill University, Department of Plant Science and focused on plant- microbial signaling, whereby she discovered a novel bacteriocin.

Britney Hess

Britney Hess joined Ontario Genomics in 2016. In her current role, she manages OG’s investment portfolio and program which focuses on supporting companies that are commercializing genomics and engineering biology-based solutions. Britney supports the implementation of strategic initiatives aimed at bringing new genomic-derived solutions to the Industrial Biotechnology and Natural Resource sectors and she is the main point of contact for funded projects in these sectors. She has also been instrumental in assisting with the planning and implementation of several strategic initiatives including the launch and execution of the CanadaSynBio conferences.

Previously, Britney worked at Bioenterprise Corporation as a Junior Analyst in Agricultural Technologies. She performed needs-based-analysis and provided entrepreneurs with market, industry and competitor data specific to their innovative technology.

Britney earned her Bachelor’s and Master’s degrees from the University of Western Ontario. During her Master of Management of Applied Science (MMASc) she focused on an interdisciplinary approach to technology commercialization.